BCM Advisors’s Pfizer PFE Stock Holding History

BCM Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-6,861	Closed	-$210K	–	71
2024 Q2	$210K	Buy	+6,861	New	+$189K	0.05%	66
2023 Q3	–	Sell	-5,666	Closed	-$204K	–	65
2023 Q2	$204K	Hold	5,666	–	–	0.05%	58
2023 Q1	$222K	Buy	5,666 +592	+12%	+$25.6K	0.06%	58
2022 Q4	$228K	Hold	5,074	–	–	0.06%	58
2022 Q3	$241K	Sell	5,074 -366	-7%	-$17.8K	0.07%	57
2022 Q2	$282K	Buy	5,440 +366	+7%	+$18.7K	0.08%	52
2022 Q1	$248K	Hold	5,074	–	–	0.07%	49
2021 Q4	$267K	Hold	5,074	–	–	0.07%	48
2021 Q3	$210K	Hold	5,074	–	–	0.06%	51
2021 Q2	$204K	Buy	+5,074	New	+$197K	0.06%	52
2021 Q1	–	Sell	-6,074	Closed	-$224K	–	55
2020 Q4	$224K	Sell	6,074 -328	-5%	-$12K	0.07%	52
2020 Q3	$215K	Buy	+6,402	New	+$224K	0.08%	51
2019 Q3	–	Sell	-5,348	Closed	-$220K	–	39
2019 Q2	$220K	Hold	5,348	–	–	0.1%	37
2019 Q1	$215K	Hold	5,348	–	–	0.1%	36
2018 Q4	$221K	Hold	5,348	–	–	0.11%	36
2018 Q3	$224K	Buy	+5,348	New	+$206K	0.12%	37
2017 Q1	–	Sell	-4,313	Closed	-$133K	–	72
2016 Q4	$133K	Buy	+4,313	New	+$132K	0.09%	35

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BCM Advisors's PFE Position: Q3 2024 in Review

BCM Advisors sold out of Pfizer (PFE) in Q3 2024, closing a stake of 6,861 shares — an estimated $210K sold.

BCM Advisors first reported a position in PFE in Q4 2016 and held it in 17 quarters. The position peaked at $282K in Q2 2022. 2,910 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

BCM Advisors reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
BCM Advisors sold 6,861 Pfizer shares in Q3 2024, an estimated $210K.
BCM Advisors first reported a position in Pfizer in Q4 2016 and held it in 17 quarters.
BCM Advisors's Pfizer position peaked at $282K in Q2 2022.
2,910 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on BCM Advisors's 13F filing for Q3 2024, filed 6 Nov 2024.